Proactiveinvestors recommends
Additional Information
Market: TSX
Sector: General Mining
EPIC: CYU
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Columbia Yukon Explorations
www.columbiayukon.com

Columbia Yukon Explorations is a mineral exploration company. Its most advanced property is the Storie molybdenum deposit located near the historic mining camp of Cassiar, B.C. The Storie deposit has a February 2009 NI 43-101 compliant Indicated and Measured Resource of 139.82 M/tonnes grading 0.064% and 58.39 M/tonnes of Inferred Resource grading 0.059% Mo at a 0.030% cut off.

Full Columbia Yukon Explorations profile here
Pdf

Columbia Yukon Explorations surges on molybdenum resource estimate for Storie Property

4th Mar 2009, 12:00 am by Ian Mclelland
Columbia Yukon Explorations surges on molybdenum resource estimate for Storie Property

TSX Venture exchange listed mining junior, Columbia Yukon Explorations (TSX-V: CYU) surged 28% in trading after the company released an updated 43-101 compliant resource estimate for the Storie Property molybdenum deposit in British Columbia.


The resource estimate, prepared by Mintec, took into account an extensive drilling program completed by the company during the 2008 season. The total current estimated total of both the Measured and Indicated Resource categories now stands at 139.82 million tonnes grading 0.064% Molybdenum at a cutoff of 0.030%. A further 58.39 million tonnes grading 0.059% Molybdenum at a cutoff of 0.030% sits in the inferred category.


Columbia Yukon was also keen to point out that the deposit still remains open in the three directions, offering plenty of scope to add further tonnage to the project.


“Columbia Yukon's 2006, 2007 and 2008 work focused on increasing, verifying and upgrading resources which were previously known. Further, to the deposit remaining open, there is at least one untested molybdenum occurrence (the "M" Zone) which merits further investigation,” the company stated.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.